The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,956.00
Bid: 4,968.00
Ask: 4,970.00
Change: 38.00 (0.77%)
Spread: 2.00 (0.04%)
Open: 4,934.00
High: 5,015.00
Low: 4,916.00
Prev. Close: 4,918.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

19 Nov 2012 07:00

RNS Number : 3893R
Intertek Group PLC
19 November 2012
 



Interim Management Statement

Intertek Group plc ("Intertek"), a leading provider of quality and safety services to a wide range of industries around the world, today releases its Interim Management Statement for the period from 1 July to 18 November 2012. Where stated, financial results are for the period from 1 January to 31 October 2012 ("period"). All comparative comments in this statement reflect comparisons with the corresponding period during 2011. The Group's full year results to 31 December 2012 will be announced on 4 March 2013.

 

Total reported revenue growth for the period was 20.1%. Organic revenue growth for the period was 9.1% at constant exchange rates (excluding acquisitions made in 2011 and 2012).

 

Each division reported strong organic revenue growth from July to October. The fast growth in the Industry & Assurance and Commodities divisions in the first half of the year, moderated as expected, to high single digits. Growth in the Consumer Goods and Commercial & Electrical divisions continued at high single digits and the Chemicals & Pharma division saw growth improve. The strongest growth has come predominantly from the Americas, Asia and the Middle East, with Europe growing below the Group average. With global economic conditions remaining uncertain, the Group will ensure operations are aligned with customer demand.

 

Since the half year results there have been two notable corporate developments: the acquisition of a non-destructive testing company (NDT Services Ltd) in the UK for £17m; and the formation of a long term partnership with the Quality and Conformity Council of Abu Dhabi (QCC). The acquisition enhances Intertek's existing services to the energy, petrochemical, power and aerospace industries in a strongly growing market. The partnership with QCC, which will initially provide advisory services for the quality programmes in Abu Dhabi across a number of industries, validates Intertek's strength and position as a leading provider of outsourced global quality solutions.

 

For the full year, the Group's adjusted operating profit margin is expected to be stable on the prior year.

 

There has been no significant change to the Group's financial position in the period since the last reported balance sheet date of 30 June 2012.

 

 

Wolfhart Hauser, Chief Executive Officer, said:

 

"Intertek has consistently produced strong organic revenue growth and we have continued this performance so far in 2012 with growth of 9.1%. We see good structural growth across many of our industries and geographies while, as expected due to the unstable global economic conditions, growth in other markets has moderated from the very strong levels seen in the first half.

 

"The compelling long term structural drivers for quality and safety services across a broad range of industries and geographies and our focus on supporting our customers will help our business to grow organic revenue at high single digits through the economic cycle."

 

-ends-

Contacts

Aston Swift, Intertek

Telephone: +44 (0) 20 7396 3400

aston.swift@intertek.com 

 

Richard Mountain, FTI Consulting

Telephone: +44 (0) 20 7269 7186

richard.mountain@fticonsulting.com

ABOUT INTERTEK

Intertek is a leading provider of quality and safety solutions serving a wide range of industries around the world. From auditing and inspection, to testing, quality assurance and certification, Intertek people are dedicated to adding value to customers' products and processes, supporting their success in the global marketplace. Intertek has the expertise, resources and global reach to support its customers through its network of more than 1,000 laboratories and offices and 33,000 people in over 100 countries around the world. Intertek Group plc (LSE: ITRK) is listed on the London Stock Exchange and is a constituent of the FTSE 100 index.

 

www.intertek.com

This Interim Management Statement is prepared for and addressed only to the Company's shareholders as a whole and to no other person. The Company, its directors, employees, agents or advisers do not accept or assume responsibility to any other person to whom this Interim Management Statement is shown or into whose hands it may come and any such responsibility or liability is expressly disclaimed. Statements contained in this Interim Management Statement are based on the knowledge and information available to the Company's Directors at the date it was prepared and therefore the facts stated and views expressed may change after that date. By their nature, the statements concerning the risks and uncertainties facing the Company in this Interim Management Statement involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. To the extent that this Interim Management Statement contains any statement dealing with any time after the date of its preparation such statement is merely predictive and speculative as it relates to events and circumstances which are yet to occur. The Company undertakes no obligation to update these forward-looking statements.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBIBDBIDBBGDL
Date   Source Headline
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement
23rd May 20221:00 pmRNSBlock listing Interim Review
4th Apr 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
18th Mar 20229:00 amRNSAnnual Financial Report
14th Mar 20221:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.